AGITG ASCEND: Randomised, Double-Blind Phase II Study of Certepetide or Placebo Added to Gemcitabine Plus Nab-Paclitaxel in Patients with Untreated Metastatic Pancreatic Ductal Adenocarcinoma: Initial Results.
Journal of Clinical Oncology(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要